comparemela.com

Latest Breaking News On - சாட் மெஸர் - Page 1 : comparemela.com

Cytokinetics, Incorporated (CYTK) Q2 2021 Earnings Call Transcript

Cytokinetics, Incorporated (CYTK) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

G1 Therapeutics, inc (GTHX) Q2 2021 Earnings Call Transcript

Operator Good day. Thank you for standing by, and welcome to the G1 Therapeutics Second Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions] I would now like to turn the conference over to your host, Mr. Will Roberts. Please go ahead, sir. William Roberts Vice President of Investor Relations & Corporate Communications Thank you, Sarah. Good afternoon, everyone, and welcome to the G1 conference call to discuss our second quarter 2021 financial results and business update. The press release on these financial results was issued after market closed this afternoon and can be found in the News section of our corporate website, G1therapeutics.com. On this call, the team will provide a business overview of the second quarter of 2021, including an update on our launch progress in that period with COSELA which was

Esperion Therapeutics, inc (ESPR) Q2 2021 Earnings Call Transcript

Operator Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions]. Following the presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to Ben Church, Investor Relations and Corporate Communications at Esperion. Please go ahead, sir. Benjamin Church Head, Corporate Communications & Investor Relations Thank you, operator. Good morning and welcome to Esperion s Second Quarter 2021 Financial Results and Company Update Conference Call. I m Ben Church and I m responsible for Investor Relations and Corporate Communications here at Esperion. I want to remind callers that the information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements.

(ALPMF), ASTELLAS PHARMA INC (ALPMY) - Analysts See Higher Success Chances For Cytokinetics Heart Disease Candidate After Positive Phase 2 Data

(ALPMF), ASTELLAS PHARMA INC (ALPMY) - Analysts See Higher Success Chances For Cytokinetics Heart Disease Candidate After Positive Phase 2 Data
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.